{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:10:02Z","timestamp":1759065002201,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Health of Russian Federation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.antiviral.2019.104617","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T01:39:06Z","timestamp":1570239546000},"page":"104617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection"],"prefix":"10.1016","volume":"172","author":[{"given":"Dmitry","family":"Shcheblyakov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Esmagambetov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Simakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Kostina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Kozlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeryi","family":"Tsibezov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Grebennikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy","family":"Chifanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Rumyantseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Boyarskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Sizikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Shagarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0410lexandr","family":"Andrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Shatohina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Syromyatnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Kovalchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Pantyukhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Zubkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Tukhvatulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Logunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Naroditsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr","family":"Gintsburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104617_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/srep06881","article-title":"Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus","volume":"4","author":"Audet","year":"2014","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.antiviral.2019.104617_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2015-09-625343","article-title":"Influence of immunoglobulin isotype on therapeutic antibody function","volume":"127","author":"Beers","year":"2016","journal-title":"Blood"},{"year":"2019","series-title":"2014-2016 Ebola Outbreak in West Africa","author":"CDC","key":"10.1016\/j.antiviral.2019.104617_bib3"},{"author":"Clinicaltrials","key":"10.1016\/j.antiviral.2019.104617_bib4"},{"key":"10.1016\/j.antiviral.2019.104617_bib5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.antiviral.2019.104617_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I\/II trial in healthy adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"author":"ECDC","key":"10.1016\/j.antiviral.2019.104617_bib7"},{"key":"10.1016\/j.antiviral.2019.104617_bib8","first-page":"1","article-title":"Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead","volume":"26","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2015","journal-title":"Crit. Rev. Biotechnol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104617_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12992-016-0194-4","article-title":"Understanding ebola: the 2014 epidemic","volume":"12","author":"Kaner","year":"2016","journal-title":"Glob. Health"},{"key":"10.1016\/j.antiviral.2019.104617_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"Kohler","year":"1975","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.antiviral.2019.104617_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/13543784.2016.1240785","article-title":"Monoclonal antibodies for the treatment of Ebola virus disease","volume":"25","author":"Moekotte","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2019.104617_bib12","doi-asserted-by":"crossref","first-page":"17182","DOI":"10.1073\/pnas.1414164111","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104617_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001575","article-title":"Ebola GP-specific monoclonal antibodies protect mice and Guinea pigs from lethal Ebola virus infection","volume":"6","author":"Qiu","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"138","key":"10.1016\/j.antiviral.2019.104617_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003876","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104617_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.32607\/20758251-2014-6-1-76-84","article-title":"Protective immune response against Bacillus anthracis induced by intranasal introduction of a recombinant adenovirus expressing the protective antigen fused to the Fc-fragment of IgG2a","volume":"6","author":"Shcherbinin","year":"2014","journal-title":"Acta Naturae"},{"key":"10.1016\/j.antiviral.2019.104617_bib16","first-page":"280","article-title":"Practical and theory of enzyme immunoassay","author":"Tjissen","year":"1985","journal-title":"Lab. Tech. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104617_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191574","article-title":"Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts","volume":"13","author":"Tutykhina","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.antiviral.2019.104617_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a human antibody cocktail that deploys multiple functions to confer Pan-ebolavirus protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:18Z","timestamp":1759062558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":18,"alternative-id":["S0166354219304644"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104617","relation":{},"ISSN":["0166-3542"],"issn-type":[{"type":"print","value":"0166-3542"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104617"}}